Jennifer Zeinecker

Initiating patients on antiretroviral therapy at CD4 cell counts above 200 cells/μl is associated with improved treatment outcomes in South Africa

R. Wood, C. Orrell, M. Dehlinger, 2010, AIDS.

Linkage to HIV Care and Antiretroviral Therapy in Cape Town, South Africa

S. Lawn, L. Bekker, R. Wood, 2010, PloS one.

Treatment Interruption in a Primary Care Antiretroviral Therapy Program in South Africa: Cohort Analysis of Trends and Risk Factors

N. Ford, S. Lawn, L. Bekker, 2010, Journal of acquired immune deficiency syndromes.

Efavirenz and Rifampicin in the South African Context: Is There a Need to Dose-Increase Efavirenz with Concurrent Rifampicin Therapy?

R. Wood, C. Orrell, I. Sanne, 2011, Antiviral therapy.

Nurse versus doctor management of HIV-infected patients receiving antiretroviral therapy (CIPRA-SA): a randomised non-inferiority trial

R. Wood, C. Orrell, M. Dehlinger, 2010, The Lancet.

Vicriviroc plus optimized background therapy for treatment-experienced subjects with CCR5 HIV-1 infection: final results of two randomized phase III trials.

Wayne Greaves, J. Slim, M. Nelson, 2012, The Journal of infection.

Low Rates of Nucleoside Reverse Transcriptase Inhibitor Resistance in a Well-Monitored Cohort in South Africa on Antiretroviral Therapy

R. Wood, C. Orrell, J. McIntyre, 2011, Antiviral therapy.